StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
415
This month
5
This week
1
This year
20
Today
1
Yesterday
1
Publishing Date
2023 - 02 - 02
3
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
4
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 01
3
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2022 - 01 - 21
2
2022 - 01 - 05
2
2021 - 12 - 16
2
2021 - 12 - 14
2
2021 - 11 - 24
3
2021 - 11 - 03
2
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 19
2
2021 - 08 - 12
4
2021 - 08 - 06
2
2021 - 08 - 05
6
2021 - 07 - 28
2
2021 - 07 - 08
2
2021 - 06 - 25
2
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 27
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 31
2
2021 - 03 - 20
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
2021 - 01 - 30
2
Sector
Commercial services
7
Communications
2
Consumer non-durables
3
Consumer services
1
Distribution services
1
Electronic technology
6
Energy minerals
1
Finance
4
Finance and insurance
1
Health services
9
Health technology
415
Industrial services
2
Manufacturing
138
Mining, quarrying, and oil and gas extraction
1
N/a
13
Non-energy minerals
1
Process industries
6
Producer manufacturing
8
Professional, scientific, and technical services
4
Retail trade
1
Tags
Alliances
20
America
15
Antibody
15
Application
5
Approval
5
Approved
5
Art27.13
5
Biotech
20
Breast cancer
13
Cancer
94
Cel
5
China
7
Clinical-trials-phase-iii
9
Collaboration
12
Covid
7
Covid-19
8
Diabetes
12
Diagnostic
10
Diagnostics
9
Disease
26
Drug
58
Drug delivery
12
Earnings
5
Enhertu
14
Europe
8
Events
7
Expected
8
Fda
5
Financial results
9
For
36
Global
40
Growing
13
Growth
64
Her2-
18
Immunotherapy
6
Initiated
6
Iot
8
License
10
Liver
15
Lung
8
Lung cancer
10
Market
117
N/a
314
People
8
Pharma
6
Phase 3
7
Positive
9
Regulatory
6
Report
48
Research
42
Respiratory
7
Results
20
Review
6
System
7
Test
6
Therapeutics
38
Therapy
20
Treatment
31
Trial
28
Vaccine
19
Entities
3m company
8
Abbott laboratories
47
Abbvie inc.
47
Adaptimmune therapeutics plc
4
Agilent technologies, inc.
3
Alexion pharmaceuticals, inc.
8
Alkermes plc
4
Amgen inc.
56
Aptargroup, inc.
4
Artelo biosciences, inc.
11
Astellas pharma inc
19
Astrazeneca plc
415
Avenue therapeutics, inc.
5
Aveo pharmaceuticals, inc.
5
Bausch health companies inc.
7
Baxter international inc.
10
Becton, dickinson and company
4
Biogen inc.
11
Biontech se
4
Boston scientific corporation
5
Bristol-myers squibb company
36
Compugen ltd.
3
Csl ltd
5
Eli lilly and company
61
Endo international plc
6
Exelixis, inc.
3
F-star therapeutics inc.
3
Fibrogen, inc
4
Fortress biotech, inc.
21
Galapagos nv
6
Genprex, inc.
4
Gilead sciences, inc.
8
Glaxosmithkline plc
126
Hutchison china meditech limited
10
Illumina, inc.
3
Innate pharma s.a.
3
Innate pharma sa
4
Insulet corporation
4
Johnson & johnson
83
Journey medical corp
3
Koninklijke philips n.v.
7
Mallinckrodt plc
3
Medtronic plc
9
Mitsubishi chemical holdings corp
4
Moderna, inc.
5
Mustang bio, inc.
3
Mylan n.v.
10
Neurocrine biosciences, inc.
4
Novartis ag
118
Novavax, inc.
4
Novo nordisk a/s
18
Opko health, inc.
3
Pfizer, inc.
33
Puma biotechnology inc
3
Sanofi
136
Takeda pharmaceutical company limited
16
Teva pharmaceutical industries limited
5
Teva pharmaceutical industries ltd
38
Thermo fisher scientific inc
8
Viatris inc.
15
Symbols
AAPL
705
ABB
891
ABBV
648
ABLZF
632
ABT
1037
AMGN
482
ARVL
2452
AZN
415
BDX
567
BMY
449
BNPQF
1003
BNPQY
1003
BNPZY
1002
BSX
407
CNY
996
CSCO
610
DHR
492
ERIC
1039
EXPR
436
EXTR
485
FNCTF
3528
GE
657
GLAXF
408
GOOG
536
GOOGL
536
GSK
607
HON
1100
HUBS
1010
IBM
436
INR
999
INTC
636
JNJ
2921
LLY
1135
LTUM
537
LYV
477
MDT
886
MLPY
997
MMM
644
MS
2622
MS-PE
425
MSFT
859
NOK
492
NOKBF
476
NVO
407
NVS
739
NVSEF
536
ORCL
791
PFE
509
PHG
621
PPRUF
605
PPRUY
606
SAP
964
SAPGF
699
SNOW
533
SNY
2683
SNYNF
1738
TMO
947
TOT
1024
URR
995
VZ
643
Exchanges
Amex
6
Lse
109
Nasdaq
415
Nyse
249
Tsx
1
Crawled Date
2023 - 02 - 02
3
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
3
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 02
3
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2022 - 01 - 21
2
2022 - 01 - 05
2
2021 - 12 - 16
2
2021 - 12 - 14
2
2021 - 11 - 24
3
2021 - 11 - 03
2
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 19
2
2021 - 08 - 12
4
2021 - 08 - 06
2
2021 - 08 - 05
6
2021 - 07 - 28
3
2021 - 07 - 13
2
2021 - 07 - 08
2
2021 - 06 - 25
2
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 27
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 31
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
2021 - 01 - 30
2
Crawled Time
00:00
5
00:20
2
01:00
3
01:12
1
02:00
7
03:00
11
03:10
1
04:00
7
04:09
1
04:20
1
05:00
4
06:00
11
06:20
1
07:00
10
08:00
7
09:00
15
09:07
1
10:00
9
11:00
22
12:00
27
12:15
2
12:20
6
12:30
4
13:00
18
13:02
1
13:15
5
13:20
7
13:30
6
14:00
22
14:15
3
14:20
3
14:30
1
15:00
22
15:15
2
15:20
8
15:30
2
15:37
1
16:00
26
16:20
1
17:00
25
17:15
1
17:20
1
18:00
23
18:12
1
19:00
18
19:11
1
20:00
19
20:20
1
21:00
20
21:03
1
22:00
9
22:10
1
23:00
6
23:05
1
23:09
1
Source
investor.aveooncology.com
2
ir.chemocentryx.com
1
www.biospace.com
101
www.chi-med.com
2
www.globenewswire.com
44
www.prnewswire.com
264
www.sutrobio.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
AZN
save search
Fortress Biotech Announces Pricing of $13.9 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published:
2023-02-08
(Crawled : 15:20)
- biospace.com/
FBIO
|
$0.7948
-4.81%
1.5M
|
Health Technology
|
0.0%
|
O:
-12.84%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
0.0%
|
O:
2.6%
H:
0.0%
C:
0.0%
offering
nasdaq
biotech
direct
Pulmonary Arterial Hypertension (PAH) Drugs Global Market 2022: Sector to Reach $9.4 Billion by 2027 at a CAGR of 5.29%
Published:
2023-02-03
(Crawled : 12:00)
- prnewswire.com
JNJ
|
$164.18
0.48%
2.6M
|
Health Technology
|
-0.88%
|
O:
1.7%
H:
0.0%
C:
0.0%
GSK
|
$36.445
0.76%
1.8M
|
Health Technology
|
1.55%
|
O:
-0.2%
H:
0.0%
C:
0.0%
UTHR
|
$254.27
-0.54%
90K
|
Health Technology
|
-1.45%
|
O:
0.59%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
0.27%
|
O:
0.47%
H:
0.0%
C:
0.0%
global
hypertension
market
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossExpects to Commence Phase 2a of CAReS During the First Quarter of 2023
Published:
2023-02-02
(Crawled : 15:20)
- biospace.com/
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-0.06%
|
O:
-0.33%
H:
0.0%
C:
0.0%
ARTL
A
|
$3.0
9.8K
|
Health Technology
|
-2.86%
|
O:
-1.27%
H:
0.0%
C:
0.0%
art27
treatment
cares
for
trial
art27.13
phase 2b
TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
Published:
2023-02-02
(Crawled : 15:00)
- biospace.com/
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-0.06%
|
O:
-0.33%
H:
0.0%
C:
0.0%
tezspire
for
approved
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published:
2023-02-02
(Crawled : 14:20)
- globenewswire.com
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-0.06%
|
O:
-0.33%
H:
0.0%
C:
0.0%
ARTL
A
|
$3.0
9.8K
|
Health Technology
|
-2.86%
|
O:
-1.27%
H:
0.0%
C:
0.0%
art27
treatment
cares
for
trial
art27.13
phase 2b
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner
Published:
2023-01-31
(Crawled : 12:20)
- prnewswire.com
JNJ
|
$164.18
0.48%
2.6M
|
Health Technology
|
-3.84%
|
O:
-3.75%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-4.25%
|
O:
-1.96%
H:
0.52%
C:
0.51%
growth
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published:
2023-01-30
(Crawled : 17:00)
- prnewswire.com
TAK
|
$16.155
1.48%
1.2M
|
Health Technology
|
-1.43%
|
O:
-0.31%
H:
0.0%
C:
0.0%
PFE
|
$43.995
0.93%
7.9M
|
Health Technology
|
-0.77%
|
O:
-0.79%
H:
0.0%
C:
0.0%
JNJ
|
$164.18
0.48%
2.6M
|
Health Technology
|
-4.1%
|
O:
-0.26%
H:
0.0%
C:
0.0%
ABT
|
$110.32
-1.49%
1.5M
|
Health Technology
|
0.14%
|
O:
-0.59%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-2.86%
|
O:
1.45%
H:
0.0%
C:
0.0%
global
report
gastrointestinal
therapeutics
market
TROPION-Lung07 Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan in Combination with Pembrolizumab in Patients with Previously Untreated Metastatic Non-Small Cell Lung Cancer
Published:
2023-01-30
(Crawled : 14:00)
- biospace.com/
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-2.86%
|
O:
1.45%
H:
0.0%
C:
0.0%
lung
trial
cancer
initiated
GERD market size to increase by USD 908.49 million; North America to account for 38% of market growth - Technavio
Published:
2023-01-25
(Crawled : 03:00)
- prnewswire.com
GSK
|
$36.445
0.76%
1.8M
|
Health Technology
|
3.07%
|
O:
0.26%
H:
0.0%
C:
0.0%
ABT
|
$110.32
-1.49%
1.5M
|
Health Technology
|
-1.93%
|
O:
-2.56%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-3.92%
|
O:
-0.2%
H:
0.0%
C:
0.0%
america
for
growth
market
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
Published:
2023-01-23
(Crawled : 13:00)
- biospace.com/
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-8.74%
|
O:
-1.28%
H:
0.57%
C:
-1.6%
acquire
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published:
2023-01-18
(Crawled : 18:00)
- prnewswire.com
VTRS
|
$12.025
-0.7%
1.6M
|
Health Technology
|
1.77%
|
O:
-0.17%
H:
0.25%
C:
-2.96%
TMO
|
$582.8
-0.06%
460K
|
Health Technology
|
-2.59%
|
O:
0.56%
H:
0.97%
C:
-1.87%
NVO
|
$139.75
0.12%
720K
|
Health Technology
|
-0.41%
|
O:
0.57%
H:
0.84%
C:
-0.01%
NVS
|
$87.315
1.13%
1.1M
|
Health Technology
|
-8.04%
|
O:
0.08%
H:
0.01%
C:
-1.16%
JNJ
|
$164.18
0.48%
2.6M
|
Health Technology
|
-7.26%
|
O:
-1.47%
H:
0.0%
C:
0.0%
GSK
|
$36.445
0.76%
1.8M
|
Health Technology
|
1.15%
|
O:
-0.03%
H:
0.17%
C:
-1.01%
LLY
M
|
$341.98
0.68%
990K
|
Health Technology
|
-6.92%
|
O:
-1.13%
H:
0.0%
C:
0.0%
ABT
|
$110.32
-1.49%
1.5M
|
Health Technology
|
-2.33%
|
O:
-0.16%
H:
0.33%
C:
-1.5%
SNY
|
$47.66
1.47%
1M
|
Health Technology
|
-7.1%
|
O:
-0.14%
H:
0.0%
C:
0.0%
BIIB
A
|
$287.96
-1.19%
240K
|
Health Technology
|
-0.45%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-10.21%
|
O:
1.36%
H:
0.33%
C:
-1.13%
AMGN
|
$241.32
-1.1%
1.1M
|
Health Technology
|
-9.49%
|
O:
0.0%
H:
0.41%
C:
-1.87%
for
therapy
growth
HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China
Published:
2023-01-18
(Crawled : 15:00)
- globenewswire.com
HCM
|
$18.26
-0.6%
37K
|
Health Technology
|
9.6%
|
O:
1.32%
H:
4.49%
C:
1.01%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-10.21%
|
O:
1.36%
H:
0.33%
C:
-1.13%
orpathys
drug
for
agreement
china
Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY OBJECTIVES
Published:
2023-01-17
(Crawled : 17:00)
- globenewswire.com
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-10.55%
|
O:
0.86%
H:
0.03%
C:
-1.23%
group
The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published:
2023-01-13
(Crawled : 13:00)
- prnewswire.com
TAK
|
$16.155
1.48%
1.2M
|
Health Technology
|
1.06%
|
O:
0.96%
H:
0.0%
C:
0.0%
PFE
|
$43.995
0.93%
7.9M
|
Health Technology
|
-7.28%
|
O:
1.08%
H:
0.0%
C:
0.0%
NVS
|
$87.315
1.13%
1.1M
|
Health Technology
|
-4.87%
|
O:
0.8%
H:
0.0%
C:
0.0%
JNJ
|
$164.18
0.48%
2.6M
|
Health Technology
|
-7.15%
|
O:
-0.39%
H:
0.0%
C:
0.0%
LLY
M
|
$341.98
0.68%
990K
|
Health Technology
|
-6.14%
|
O:
0.4%
H:
0.0%
C:
0.0%
SNY
|
$47.66
1.47%
1M
|
Health Technology
|
-4.29%
|
O:
1.89%
H:
0.0%
C:
0.0%
BMRN
|
$110.94
-0.33%
400K
|
Health Technology
|
0.51%
|
O:
2.13%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-9.02%
|
O:
1.7%
H:
0.0%
C:
0.0%
treatment
disease
expected
Global Head And Neck Cancer Therapeutics Market Report 2022: Sector to Reach $2.5 Billion by 2028 at a 12.3% CAGR
Published:
2023-01-12
(Crawled : 22:00)
- prnewswire.com
TAK
|
$16.155
1.48%
1.2M
|
Health Technology
|
1.06%
|
O:
0.96%
H:
0.0%
C:
0.0%
LLY
M
|
$341.98
0.68%
990K
|
Health Technology
|
-6.14%
|
O:
0.4%
H:
0.0%
C:
0.0%
SNY
|
$47.66
1.47%
1M
|
Health Technology
|
-4.29%
|
O:
1.89%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-9.02%
|
O:
1.7%
H:
0.0%
C:
0.0%
global
report
therapeutics
cancer
market
Global Nasal Vaccines Markets and Pipeline Analysis Research Report 2022: A Major Game Changer in Blocking the Transmission of Diseases Such as COVID-19
Published:
2023-01-10
(Crawled : 21:00)
- prnewswire.com
AZNCF
|
$128.7
0
|
Health Technology
|
-12.53%
|
O:
-1.28%
H:
0.0%
C:
-0.82%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-11.28%
|
O:
-0.33%
H:
0.13%
C:
-1.28%
covid-19
research
global
report
Immune Checkpoint Inhibitors Market Predicted to Reach USD 155.1 Billion, Globally, by 2031 at 16.1% CAGR: Allied Market Research
Published:
2023-01-09
(Crawled : 10:00)
- prnewswire.com
GSK
|
$36.445
0.76%
1.8M
|
Health Technology
|
4.7%
|
O:
1.76%
H:
0.0%
C:
0.0%
LLY
M
|
$341.98
0.68%
990K
|
Health Technology
|
-6.55%
|
O:
1.12%
H:
0.27%
C:
-3.89%
SNY
|
$47.66
1.47%
1M
|
Health Technology
|
-3.06%
|
O:
1.82%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-9.1%
|
O:
1.67%
H:
0.86%
C:
-0.21%
research
market
Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer
Published:
2023-01-05
(Crawled : 16:00)
- biospace.com/
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-9.93%
|
O:
-2.09%
H:
0.0%
C:
0.0%
lung
for
biomarker
cancer
study
Genomic Vision announces successful beta testing of FiberSmart®
Published:
2023-01-05
(Crawled : 07:00)
- globenewswire.com
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-9.93%
|
O:
-2.09%
H:
0.0%
C:
0.0%
fibersmart
genomic
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published:
2023-01-04
(Crawled : 23:00)
- prnewswire.com
NVS
|
$87.315
1.13%
1.1M
|
Health Technology
|
-6.71%
|
O:
-0.84%
H:
0.0%
C:
0.0%
JNJ
|
$164.18
0.48%
2.6M
|
Health Technology
|
-9.63%
|
O:
0.22%
H:
0.0%
C:
0.0%
SNY
|
$47.66
1.47%
1M
|
Health Technology
|
-6.01%
|
O:
-3.07%
H:
0.0%
C:
0.0%
AZN
|
$64.645
0.55%
3M
|
Health Technology
|
-9.93%
|
O:
-2.09%
H:
0.0%
C:
0.0%
treatment
patent
global
report
growing
diabetes
growth
market
← Previous
1
2
3
4
5
6
7
8
9
…
20
21
Next →
Gainers vs Losers
54%
46%
Top 10 Gainers
DGLY
|
$5.43
1722.15%
160K
|
Electronic Technology
CELZ
|
$1.115
115.54%
120M
|
AVRO
|
$1.78
104.01%
11M
|
Health Technology
GFAI
|
$0.4936
44.54%
62M
|
WETG
|
$0.551
34.39%
13M
|
KPRX
|
$6.11
34.29%
15M
|
Manufacturing
PRFX
|
$0.65
30.0%
13M
|
Health Technology
BBLG
|
$0.3799
20.76%
740K
|
n/a
NEWR
A
|
$77.25
19.62%
2.7M
|
Technology Services
THCH
|
$4.99
18.81%
560K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.